OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom, Finland, and Italy.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom, Finland, and Italy.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Ireland.
In IrelandThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
In CanadaThis study is recruiting in Indonesia. It focuses on schizophrenia.
In IndonesiaThis study is recruiting in the United States, in France, in Canada, .... It is testing KarXT for Schizophrenia.
Multiple locations, including HomewoodThis study is recruiting in Netherlands. It focuses on schizophrenia.
In NetherlandsThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
Multiple locations, including Scarborough VillageThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Germany.
In Berlin